Family Medicine · Glendale, CA
NPI
1750477279
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
445 W. Broadway
Glendale, CA, 91204
Phone (818) 241-2103
Groups this clinician bills Medicare through
Medicare paid, 2024
$197K
3,763 services
Medicare patients, 2024
795
Average age 75
Drug cost, 2024
$5.8M
59,823 prescriptions
Company payments, 2025
$138
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Henrik Khatchatourian was code 99213 (office e&m - established), 1,546 times for 677 patients. In total Henrik Khatchatourian billed 3,763 services in 32 codes, and Medicare paid $197K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,546 | 677 | $68.23 | $105K |
| 36415 Venipuncture Blood Collection | Office | 648 | 472 | $8.65 | $5,605 |
| 99212 Office E&M - Established | Office | 542 | 331 | $43.36 | $24K |
| 99214 Office E&M - Established | Office | 200 | 184 | $92.91 | $19K |
| 93000 Electrocardiogram | Office | 110 | 100 | $10.99 | $1,209 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 93 | 83 | $178.36 | $17K |
| 96372 Injection Administration | Office | 83 | 54 | $11.44 | $949 |
| 97032 PT Treatment | Office | 67 | 12 | $8.71 | $583 |
| 97140 PT Treatment | Office | 67 | 12 | $15.96 | $1,069 |
| 97110 PT Treatment | Office | 67 | 12 | $23.08 | $1,546 |
| 97035 PT Treatment | Office | 65 | 12 | $8.15 | $530 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 50 | 44 | $24.32 | $1,216 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 47 | 47 | $127.54 | $5,994 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 39 | 39 | $19.15 | $747 |
| 99204 Office E&M - New | Office | 26 | 26 | $122.75 | $3,191 |
By year: 2022 $228K for 4,243 services; 2023 $230K for 4,109 services; 2024 $197K for 3,763 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 648 | 472 | $8.65 | $5,605 |
Medicare prescription drug claims, 2024
In 2024, the drug Henrik Khatchatourian prescribed most often to Medicare patients was Icosapent Ethyl, with 2,487 prescriptions and refills. In total Henrik Khatchatourian wrote 59,823 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Icosapent Ethyl Generic | 2,487 | 2,696 | 372 | $376K |
| Atorvastatin Calcium Generic | 2,239 | 2,508 | 242 | $4,339 |
| Amlodipine Besylate Generic | 2,125 | 2,309 | 231 | $2,099 |
| Diclofenac Sodium Generic | 1,982 | 2,127 | 266 | $1.2M |
| Rosuvastatin Calcium Generic | 1,848 | 2,108 | 208 | $5,561 |
| Meclizine Hcl Generic | 1,708 | 1,791 | 180 | $9,875 |
| Metformin Hcl Generic | 1,469 | 1,643 | 159 | $67K |
| Pantoprazole Sodium Generic | 1,462 | 1,601 | 170 | $4,188 |
| Tamsulosin Hcl Generic | 1,432 | 1,565 | 149 | $5,143 |
| Vascepa Icosapent Ethyl | 1,423 | 1,494 | 186 | $348K |
| Dexlansoprazole Dr Dexlansoprazole | 1,381 | 1,461 | 159 | $228K |
| Gabapentin Generic | 1,313 | 1,415 | 156 | $2,986 |
| Levothyroxine Sodium Generic | 1,228 | 1,369 | 117 | $4,120 |
| Lisinopril Generic | 1,128 | 1,239 | 117 | $1,513 |
| Ibuprofen Generic | 1,000 | 1,014 | 128 | $3,957 |
Brand drugs: 8,416 claims; generic drugs: 50,280 claims; opioid claims: 163.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Henrik Khatchatourian $138 ($138 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $41.97.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.